You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Selegiline - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for selegiline and what is the scope of patent protection?

Selegiline is the generic ingredient in four branded drugs marketed by Somerset, Apotex, Lannett Co Inc, Novitium Pharma, Rising, Bausch, Apotex Inc, Bayshore Pharms Llc, Chartwell Molecules, Cosette, Dash Pharms Natco, G And W Labs Inc, and I3 Pharms, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for selegiline. One supplier is listed for this compound.

Drug Prices for selegiline

See drug prices for selegiline

Recent Clinical Trials for selegiline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of IbadanPhase 1/Phase 2
E-Group ICT Software Informatikai Zrt.Phase 2
László MangelPhase 2

See all selegiline clinical trials

Medical Subject Heading (MeSH) Categories for selegiline
Anatomical Therapeutic Chemical (ATC) Classes for selegiline

US Patents and Regulatory Information for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075145-001 Sep 15, 2003 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075321-001 Dec 4, 1998 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
I3 Pharms SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074672-001 Apr 1, 1997 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rising SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 206803-001 Apr 2, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.